Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1953733 | 0.84 | TP53 (0.38) | CA12CA14LMNAKMT2ACYP2D6 | |
| SCHEMBL1332536 | 0.84 | TP53 (0.38) | CA12CA14LMNAKMT2ACYP2D6 | |
| SCHEMBL305050 | 0.84 | TP53 (0.38) | CA12CA14LMNAKMT2ACYP2D6 | |
| SCHEMBL24045977 | 0.81 | CA1 (0.34) | CA12CA14LMNAKMT2ACYP2D6 | |
| SCHEMBL13647345 | 0.81 | TSHR (0.41) | CA12CA14LMNAKMT2ACA1 | |
| SCHEMBL18206813 | 0.80 | TSHR (0.44) | CA12CA14LMNAKMT2ACA1 | |
| SCHEMBL7361094 | 0.80 | TSHR (0.44) | CA12CA14LMNAKMT2ACA1 | |
| SCHEMBL7361092 | 0.80 | TSHR (0.44) | CA12CA14LMNAKMT2ACA1 | |
| SCHEMBL18032856 | 0.79 | CA1 (0.33) | CA12CA14LMNAKMT2ACYP2D6 | |
| SCHEMBL4622814 | 0.78 | NOS1 (0.37) | CA12CA14LMNAKMT2ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003016259-A2 | COMPOUNDS CONTAINING LACTIC ACID ELEMENTS, METHOD FOR THE PRODUCTION AND USE THEREOF AS PHARMACEUTICALLY ACTIVE SUBSTANCES | PHARMACON-FORSCHUNG UND BERATUNG GMBH (AT) | 2003-02-27 | — | — | WO | disclosed |